Company & Sponsor Intelligence
Brigham and Women's Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials16
Recruiting6
Completed6
Countries1
Therapeutic footprint
alzheimersdepressionepilepsymultiple_sclerosisout_of_scopepain_neuropathyparkinsonsptsdsubstance_use
Indexed studies
NCT07043738Imaging- vs. Scalp-Targeted Accelerated TMS for Depression: The Number Needed to Scan Trial
depression · NA
depression · NA
NCT045102209-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis
multiple_sclerosis · United StatesPHASE3
multiple_sclerosis · United StatesPHASE3
NCT02649985PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
alzheimers · United StatesPHASE1, PHASE2
alzheimers · United StatesPHASE1, PHASE2
NCT05040321Sirtuin-NAD Activator in Alzheimer's Disease
alzheimers · United StatesPHASE1, PHASE2
alzheimers · United StatesPHASE1, PHASE2
NCT06983327Brief Intervention for Chronic Pain and History of Stressful Experiences
pain_neuropathy · United StatesNA
pain_neuropathy · United StatesNA
NCT06330753Synergy Between Patient and Clinician: Using a Trauma-Informed Care Plan
ptsd · United StatesNA
ptsd · United StatesNA
NCT06804668Safety and Feasibility of Tele-supervised Home-based Transcranial Direct Current Stimulation in Parkinson's Disease
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT03868293Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial
epilepsy · United StatesNA
epilepsy · United StatesNA
NCT06639464Semaglutide for Helping Opioid Recovery
substance_use · United StatesPHASE2
substance_use · United StatesPHASE2
NCT02419638Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS
multiple_sclerosis · United StatesWITHDRAWN
multiple_sclerosis · United StatesWITHDRAWN
NCT05329779Study on Allopregnanolone and Depression in Perimenopausal Women
depression · United StatesPHASE4
depression · United StatesPHASE4
NCT04045990Network Modulation in Alzheimer's Disease
alzheimers · United StatesNA
alzheimers · United StatesNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →